The First Egyptian Report Showing the Co-Existence of bla_NDM-25, bla_OXA-23, bla_OXA-181, and bla_GES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR

References

• Codjoe FS, Donkor ES. Carbapenem resistance: review. Med Sci. 2018;6(1). doi:10.3390/medsci6010001
   Google Scholar
• Neuner EA, Yeh J-Y, Hall GS, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis. 2011;69(4):357–362. doi:10.1016/j.diagmicrobio.2010.10.01321396529
   PubMed Web of Science ®Google Scholar
• Huttner B, Jones M, Rubin MA, Neuhauser MM, Gundlapalli A, Samore M. Drugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005–2010. PLoS One. 2012;7(5):e36649. doi:10.1371/journal.pone.003664922615789
   PubMed Web of Science ®Google Scholar
• El-Badawy MF, Abdelwahab SF, Alghamdi SA, Shohayeb MM. Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia. Infect Drug Resist. 2019;12:3113–3124. doi:10.2147/IDR.S20669131632100
   PubMed Web of Science ®Google Scholar
• Wolfensberger A, Kuster SP, Marchesi M, Zbinden R, Hombach M. The effect of varying multidrug-resistance (MDR) definitions on rates of MDR Gram-negative rods. Antimicrob Resist Infect Control. 2019;8(1). doi:10.1186/s13756-019-0614-3
   Web of Science ®Google Scholar
• Pattnaik D, Panda SS, Singh N, Sahoo S, Mohapatra I, Jena J. Multidrug resistant, extensively drug resistant and pan drug resistant Gram-negative bacteria at a tertiary care center in Bhubaneswar. Int J Community Med Public Heal. 2019;6(2):567–572. doi:10.18203/2394-6040.ijcmph20190170
   Google Scholar
• Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016;3(1):15–21. doi:10.1177/204993611562170926862399
   PubMed Web of Science ®Google Scholar
• Naas T, Dortet L,I, Iorga B. Structural and functional aspects of class A carbapenemases. Curr Drug Targets. 2016;17(9):1006–1028. doi:10.2174/138945011766616031014450126960341
   PubMed Web of Science ®Google Scholar
• Brouwer MS, Tehrani KH, Rapallini M, et al. Novel carbapenemases FLC-1 and IMI-2 encoded by an Enterobacter cloaca complex isolated from food products. Antimicrob Agents Chemother. 2019;63(6):e02338–02318. doi:10.1128/AAC.02338-1830910900
   PubMed Web of Science ®Google Scholar
• Antunes NT, Lamoureaux TL, Toth M, Stewart NK, Frase H, Vakulenko SB. Class D β- lactamases: are they all carbapenemases? Antimicrob Agents Chemother. 2014;58(4):2119–2125. doi:10.1128/AAC.02522-1324468778
   PubMed Web of Science ®Google Scholar
• Antunes NT, Fisher JF. Acquired class D β-lactamases. Antibiotics. 2014;3(3):398–434. doi:10.3390/antibiotics303039827025753
   PubMedGoogle Scholar
• Abbas HA, Kadry AA, Shaker GH, Goda RM. Impact of specific inhibitors on metallo-β- carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates. Microb Pathog. 2019;132:266–274. doi:10.1016/j.micpath.2019.05.02231096002
   PubMed Web of Science ®Google Scholar
• Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem- EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40(10):3798–3801. doi:10.1128/jcm.40.10.3798-3801.200212354884
   PubMed Web of Science ®Google Scholar
• Van Belkum A, Hermans PW. BOX PCR fingerprinting for molecular typing of Streptococcus pneumoniae In: Antibio Resist. Springer; 2001:159–168. doi:10.1385/1-59259-077-2:159
   Google Scholar
• Brusetti L, Malkhazova I, Gtari M, et al. Fluorescent-BOX-PCR for resolving bacterial genetic diversity, endemism and biogeography. BMC Microbiol. 2008;8(1):220. doi:10.1186/1471-2180-8-22019077307
   PubMed Web of Science ®Google Scholar
• El-Badawy MF, Tawakol WM, El-Far SW, et al. Molecular identification of aminoglycoside-modifying enzymes and plasmid-mediated quinolone resistance genes among klebsiella pneumoniae clinical isolates recovered from Egyptian patients. Inter J Microbiol. 2017;2017:1–12. doi:10.1155/2017/8050432
   Web of Science ®Google Scholar
• Vandepitte J, Verhaegen J, Engbaek K, et al. Basic Laboratory Procedures in Clinical Bacteriology. WHO; 2003.
   Google Scholar
• Qaiyumi S. Macro-and microdilution methods of antimicrobial susceptibility testing In: Antimicrobial Susceptibility Testing Protocols. Taylor & Francis; 2007:75–79.
   Google Scholar
• Patel J, Cockerill F, Alder J, et al. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Susceptibility Testing. 2014.
   Google Scholar
• Othman HB, Halim RMA, Abdul-Wahab HEE-A, Atta HA, Shaaban O. Pseudomonas aeruginosa-modified Hodge test (PAE-MHT) and ChromID Carba agar for detection of carbapenemase producing Pseudomonas aeruginosa recovered from clinical specimens. Macedo J Med Sci. 2018;6(12):2283–2289. doi:10.3889/oamjms.2018.414
   Google Scholar
• Campana EH, Chuster SG, da Silva IR, et al. modified Carba NP test for the detection of carbapenemase production in Gram-negative rods: optimized handling of multiple samples. Braz J Microbiol. 2017;48(2):242–245. doi:10.1016/j.bjm.2016.09.01527998674
   PubMed Web of Science ®Google Scholar
• Rudresh SM, Ravi GS, Sunitha L, Hajira SN, Kalaiarasan E, Harish BN. Simple, rapid, and cost-effective modified Carba NP test for carbapenemase detection among Gram- negative bacteria. J Lab Physician. 2017;9(4):303–307. doi:10.4103/JLP.JLP_138_16
   Google Scholar
• Sachdeva R, Sharma B, Sharma R. Evaluation of different phenotypic tests for detection of metallo-β-lactamases in imipenem-resistant Pseudomonas aeruginosa. J Lab Physician. 2017;9(4):249–253. doi:10.4103/JLP.JLP_118_16
   Google Scholar
• Van Dijk K, Voets G, Scharringa J, et al. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect. 2014;20(4):345–349. doi:10.1111/1469-0691.1232223927659
   PubMed Web of Science ®Google Scholar
• Yang Y, Rasmussen BA, Shlaes DM. Class A β-lactamases-enzyme-inhibitor interactions and resistance. Pharma& Therap. 1999;83(2):141–151. doi:doi.10.1016/S0163-7258(99)00027-3
   PubMed Web of Science ®Google Scholar
• Stojanoski V, Chow D-C, Fryszczyn B, et al. Structural basis for different substrate profiles of two closely related class D β-lactamases and their inhibition by halogens. Biochemi. 2015;54(21):3370–3380. doi:10.1021/acs.biochem.5b00298
   PubMed Web of Science ®Google Scholar
• Dobrzaniecka K, Młynarczyk A, Szymanek-Majchrzak K, Młynarczyk G. Comparison of phenotypic methods for the detection of beta-lactamases MBL in strains from the Enterobacteriaceae family and non-fermentative bacilli isolated from clinical specimens. Med Dosw Mikrobiol. 2014;66(3–4):177–184.25804071
   PubMedGoogle Scholar
• Dashti AA, Jadaon MM, Abdulsamad AM, Dashti HM. Heat treatment of bacteria: a simple method of DNA extraction for molecular techniques. Kuwait Med J. 2009;41(2):117–122.
   Web of Science ®Google Scholar
• El-Badawy MF, Tawakol WM, Maghrabi IA, Mansy MS, Shohayeb MM, Ashour MS. Iodometric and molecular detection of ESBL production among clinical isolates of E. coli fingerprinted by ERIC-PCR: the first Egyptian report declares the emergence of E. coli O25b-ST131clone harboring blaGES. Microbiol Drug Resist. 2017;23(6):703–717. doi:10.1089/mdr.2016.0181
   Google Scholar
• Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ. Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25(9):1189–1191. doi:10.1093/bioinformatics/btp03319151095
   PubMed Web of Science ®Google Scholar
• Moemen D, Masallat DT. Prevalence and characterization of carbapenem-resistant Klebsiella pneumoniae isolated from intensive care units of Mansoura university hospitals. Egypt J Bas Appli Sci. 2017;4(1):37–41. doi:10.1016/j.ejbas.2017.01.001
   Google Scholar
• Sheu -C-C, Chang Y-T, Lin S-Y, et al. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options. Front Microbiol. 2019;10(80). doi:10.3389/fmicb.2019.00080
   Web of Science ®Google Scholar
• Lledo W, Hernandez M, Lopez E, et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep CDC. 2009;58(10):256–260.
   Google Scholar
• Wiener-Well Y, Rudensky B, Yinnon A, et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalized patients during a national outbreak. J Hosp Infect. 2010;74(4):344–349. doi:10.1016/j.jhin.2009.07.02219783067
   PubMed Web of Science ®Google Scholar
• Metwally L, Gomaa N, Attallah M, Kamel N. High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt. East Mediterr Health J. 2013;19(11):947–952. doi:10.26719/2013.19.11.94724673086
   PubMed Web of Science ®Google Scholar
• Moghadampour M, Rezaei A, Faghri J. The emergence of blaOXA-48 and blaNDM among ESBL-producing Klebsiella pneumoniae in clinical isolates of a tertiary hospital in Iran. Acta Microbiol Immunol Hung. 2018;65(3):335–344. doi:10.1556/030.65.2018.03430024268
   PubMedGoogle Scholar
• Bi W, Liu H, Dunstan RA, et al. Extensively drug resistant Klebsiella pneumoniae causing nosocomial bloodstream infections in China: molecular investigation of antibiotic resistance determinants, informing therapy, and clinical outcomes. Front Microbiol. 2017;8:1230. doi:10.3389/fmicb.2017.0123028713357
   PubMed Web of Science ®Google Scholar
• Patel JB, Weinstein MP, Eliopoulos GM, et al. Carba NP Test for Suspected Carbapenemase Production in Enterobacteriaceae, Pseudomonas Aeruginosa, and Acinetobacter Spp. Clinical and Laboratory Standards Institute (CLSI). CLSI Supplement M100. 27th ed. 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Morey KE, Vega R, Cassidy PM, et al. Evaluation of the Carba NP test in Oregon, 2013. Antimicrob Agents Chemother. 2017;61(1):e03005–03015. doi:10.1128/AAC.03005-1527795386
   PubMed Web of Science ®Google Scholar
• AlTamimi M, AlSalamah A, AlKhulaifi M, AlAjlan H. Comparison of phenotypic and PCR methods for detection of carbapenemases production by Enterobacteriaceae. Saudi J Biol Sci. 2017;24(1):155–161. doi:10.1016/j.sjbs.2016.07.00428053586
   PubMed Web of Science ®Google Scholar
• Bayramoğlu G, Ulucam G, Gençoğlu ÇÖ, Kılıç A, Aydın F. Comparison of the modified Hodge test and the Carba NP test for detection of carbapenemases in Enterobacteriaceae isolates. Mikrobiyol Bu. 2016;50(1):1–10. doi:10.5578/mb.10861
   Web of Science ®Google Scholar
• Pournaras S, Poulou A, Tsakris A. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother. 2010;65(7):1319–1321. doi:10.1093/jac/dkq12420395214
   PubMed Web of Science ®Google Scholar
• Kahraman EP, Toptan H, Otlu B, Köroğlu M, Altındiş M. Investigation of blaOXA-48-like genes in carbapenemase producing Klebsiella spp. isolates. Mikrobiyol Bul. 2019;53(2):134–143. doi:10.5578/mb.6791431130118
   PubMedGoogle Scholar
• Al-Zahrani IA, Alasiri BA. The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia. Saudi Med J. 2018;39(1):23–30. doi:10.15537/smj.2018.1.2109429332105
   PubMed Web of Science ®Google Scholar
• Shankar C, Mathur P, Venkatesan M, et al. Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: multiple and varied mobile genetic elements. BMC Microbiol. 2019;19(1):137. doi:10.1186/s12866-019-1513-831234800
   PubMedGoogle Scholar
• Nahid F, Zahra R, Sandegren L. A blaOXA-181harbouring multi-resistant ST147 Klebsiella pneumoniae isolate from Pakistan that represent an intermediate stage towards pan-drug resistance. PLoS One. 2017;12(12):e0189438. doi:10.1371/journal.Pone29220374
   PubMedGoogle Scholar
• Satter S, Mahbub H, Shamsuzzaman S. OXA-181-an emerging threat in Bangladesh. J Mole Stud Medici Res. 3(01):128–134. doi:10.18801/jmsmr.030118.15
   Google Scholar
• Zhu C, Liyanapathirana V, Li C, et al. Characterizing mobilized virulence factors and multidrug resistance genes in carbapenemase-producing Klebsiella pneumoniae in a Sri Lankan hospital. Front Microbiol. 2018;9:2044. doi:10.3389/fmicb.2018.0204430233529
   PubMed Web of Science ®Google Scholar
• Uwaezuoke NS, Kieffer N, Iregbu KC, Nordmann P. First report of OXA-181 and NDM- 1 from a clinical Klebsiella pneumoniae isolate from Nigeria. Int J Infect Dis. 2017;61:1–2. doi:10.1016/j.ijid.2017.05.00428526566
   PubMed Web of Science ®Google Scholar
• Lopes BS, Al-Agamy MH, Ismail MA, et al. The transferability of blaOXA-23 gene in multidrug-resistant Acinetobacter baumannii isolates from Saudi Arabia and Egypt. Int J Med Microbiol. 2015;305(6):581–588. doi:10.1016/j.ijmm.2015.07.00726253451
   PubMed Web of Science ®Google Scholar
• Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis. 2014;22:49–54. doi:10.1016/j.ijid.2013.12.00424607428
   PubMed Web of Science ®Google Scholar
• El Bannah AMS, Nawar NN, Hassan RMM, Salem STB. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Egypt: clonal spread of blaOXA-23. Microb Drug Resist. 2018;24(3):269–277. doi:10.1089/mdr.2017.005728783427
   PubMedGoogle Scholar
• Yousfi K, Touati A, Lefebvre B, et al. Characterization of multidrug-resistant Gram-negative bacilli isolated from hospitals effluents: first report of a blaOXA-48-like in Klebsiella oxytoca, Algeria. Braz J Microbiol. 2019;50(1):175–183. doi:10.1007/s42770-018-0010-930637660
   PubMedGoogle Scholar
• Evans BA, Amyes SG. OXA-type β-lactamases. Clin Microbiol Rev. 2014;27(2):63–72. doi:10.1128/CMR.00117-13
   Web of Science ®Google Scholar
• Chen TL, Lee YT, Kuo SC, et al. Emergence and distribution of plasmids bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob Agents Chemother. 2010;54(11):4575–4581. doi:10.1128/AAC.00764-1020713680
   PubMed Web of Science ®Google Scholar
• Budak S, Aktaş Z, Oncul O, et al. Detection of OXA-51 Carbapenemase Gene in Klebsiella pneumoniae: a Case Report and a New Dimension on Carbapenemase Resistance. J Mol Genet Med. 2013;7:1747–0862.1000. doi:10.4172/1747-0862.1000063
   Google Scholar
• Lee CR, Lee JH, Park KS, et al. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol. 2016;7:895. doi:10.3389/fmicb.2016.008927379038
   PubMed Web of Science ®Google Scholar